➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
Express Scripts
Merck
Colorcon

Last Updated: October 25, 2021

DrugPatentWatch Database Preview

CYCLOSPORINE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for cyclosporine and what is the scope of patent protection?

Cyclosporine is the generic ingredient in eight branded drugs marketed by Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Sandoz, Abbvie, Novartis, Allergan, Santen, Padagis Us, West-ward Pharms Int, Sun Pharma Global, Pharm Assoc, and Wockhardt Bio Ag, and is included in twenty-one NDAs. There are twenty patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cyclosporine has one hundred and ninety-four patent family members in twenty-nine countries.

There are eighteen drug master file entries for cyclosporine. Eleven suppliers are listed for this compound.

Drug Prices for CYCLOSPORINE

See drug prices for CYCLOSPORINE

Recent Clinical Trials for CYCLOSPORINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Galderma R&DPhase 3
National Medical Research Center for Children's Health, Russian FederationPhase 4
Assiut UniversityPhase 3

See all CYCLOSPORINE clinical trials

US Patents and Regulatory Information for CYCLOSPORINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan RESTASIS cyclosporine EMULSION;OPHTHALMIC 050790-001 Dec 23, 2002 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Apotex CYCLOSPORINE cyclosporine CAPSULE;ORAL 065040-002 May 9, 2002 AB2 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Abbvie GENGRAF cyclosporine CAPSULE;ORAL 065003-003 May 12, 2000 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Allergan RESTASIS MULTIDOSE cyclosporine EMULSION;OPHTHALMIC 050790-002 Oct 27, 2016 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Apotex CYCLOSPORINE cyclosporine CAPSULE;ORAL 210721-002 Jul 10, 2019 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CYCLOSPORINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 ⤷  Try it Free ⤷  Try it Free
Novartis SANDIMMUNE cyclosporine CAPSULE;ORAL 050625-003 Nov 23, 1992 ⤷  Try it Free ⤷  Try it Free
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-002 Jul 14, 1995 ⤷  Try it Free ⤷  Try it Free
Novartis NEORAL cyclosporine SOLUTION;ORAL 050716-001 Jul 14, 1995 ⤷  Try it Free ⤷  Try it Free
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for CYCLOSPORINE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1809237 C300741 Netherlands ⤷  Try it Free PRODUCT NAME: CICLOSPORINE (EYE DROP; REGISTRATION NO/DATE: EU/1/15/990 20150319
2049079 PA2017003,C2049079 Lithuania ⤷  Try it Free PRODUCT NAME: CIKLOSPORINAS; REGISTRATION NO/DATE: EU/1/15/990 20170319
1809237 CA 2015 00030 Denmark ⤷  Try it Free PRODUCT NAME: CYCLOSPORINOEJENDRABEEMULSION; REG. NO/DATE: EU/1/15/990/001-002 20150319
2049079 LUC00006 Luxembourg ⤷  Try it Free PRODUCT NAME: CYCLOSPORINE (GOUTTES OCULAIRES SOUS FORME D'EMULSION); AUTHORISATION NUMBER AND DATE: EU/1/15/990 20150323
1809237 122015000043 Germany ⤷  Try it Free PRODUCT NAME: OPHTHALMISCHE EMULSION ENTHALTEND CYCLOSPORIN; REGISTRATION NO/DATE: EU/1/15/990 20150319
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
Express Scripts
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.